Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 10, 1997

View Archived Issues

Gruenenthal prepares analgesics

Analgesic/antiinflammatory agent from Merck KGaA

Dual-action compounds for BPH described by Zeria

Antifungal agent revealed by Bayer

ADIR prepares antiangiogenic agents

German researchers focus on Na+/H+-exchange inhibitors

Antitumor agents from Taiho

Novel omega-conotoxin peptides described

Dual leukotriene/thromboxane antagonists described by Hokuriku

Natural 5alpha-reductase inhibitors discovered at Taisho

Meiji Milk discloses new gold complex

Patent coverage granted for LXR antidiarrheal agent

Novavax retains investment bank for licensing

Medis El teams with Ramot to develop breast cancer vaccines

Catalytica to acquire Glaxo Wellcome pharmaceutical facility

TCPI and Taiho agreement for diagnostic test

Vyrex gene discovery platform receives patent coverage

Rotavirus diagnostic approved in Germany

Milestone achieved in Microcide/Pfizer collaboration

Pall establishes European manufacturing site

Grant helps fund research into camptothecin analogues

Structure of protease involved in osteoporosis solved

Introgen receives milestone payment for gene therapy progress

Launch date for Aricept revealed

Genentech funds basic research related to human birth defects

BioSpecifics Technologies is issued 9th U.S. patent for use of collagenase enzyme

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...